Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ariel Roguin

Showing results (261-270 of 283) with videos related to

Pageof 29
Sort By:
Annals of Internal Medicine|October 5, 2011
A prospective evaluation of a protocol for magnetic resonance imaging of patients with implanted cardiac devicesSaman Nazarian, Rozann Hansford, Ariel Roguin, et al.
Heart (British Cardiac Society)|January 11, 2022
Outcomes and regional differences in practice in a worldwide coronary stent registryMurat Cimci, Jawed Polad, Mamas Mamas, et al.
International Journal of Cardiovascular Interventions|December 10, 2002
Clinical and angiographic results with the beStent: the Registry for Optimal beStent Evaluation (ROSE) trialHarry Suryapranata, Jean L Boland, Michael Pieper, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 4, 2025
Elderly patients treated with Onyx versus Orsiro drug-eluting coronary stents in a randomized clinical trial with long-term follow-upDaphne van Vliet, Eline H Ploumen, Tineke H Pinxterhuis, et al.
International Journal of Cardiology. Heart & Vasculature|July 21, 2025
Impact of diabetes on three-year outcome after coronary stenting in patients with polyvascular atherosclerotic disease - a secondary analysis of the randomized TWENTE trialsDaphne van Vliet, Tineke H Pinxterhuis, Eline H Ploumen, et al.
Circulation|November 4, 2005
Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathySaman Nazarian, David A Bluemke, Albert C Lardo, et al.
Cardiovascular Diagnosis and Therapy|September 7, 2023
Outcome of percutaneous coronary intervention using ultrathin-strut biodegradable polymer sirolimus-eluting versus thin-strut durable polymer zotarolimus-eluting stents in patients with comorbid peripheral arterial disease: a post-hoc analysis from two randomized trialsTineke H Pinxterhuis, Eline H Ploumen, Paolo Zocca, et al.
Cardiovascular Intervention and Therapeutics|December 19, 2024
Clinical outcome after bleeding events following coronary stenting in patients with and without comorbid peripheral arterial diseaseTineke H Pinxterhuis, Eline H Ploumen, Marlies M Kok, et al.
Atherosclerosis|May 31, 2022
Outcome after percutaneous coronary intervention with contemporary stents in patients with concomitant peripheral arterial disease: A patient-level pooled analysis of four randomized trialsTineke H Pinxterhuis, Eline H Ploumen, Paolo Zocca, et al.
International Journal of Cardiology|December 10, 2022
Risk of bleeding after percutaneous coronary intervention and its impact on further adverse events in clinical trial participants with comorbid peripheral arterial diseaseTineke H Pinxterhuis, Eline H Ploumen, Paolo Zocca, et al.
Pageof 29

Showing results (261-270 of 283) with videos related to

Sort By:
Pageof 29
Annals of Internal Medicine|October 5, 2011
A prospective evaluation of a protocol for magnetic resonance imaging of patients with implanted cardiac devicesSaman Nazarian, Rozann Hansford, Ariel Roguin, et al.
Heart (British Cardiac Society)|January 11, 2022
Outcomes and regional differences in practice in a worldwide coronary stent registryMurat Cimci, Jawed Polad, Mamas Mamas, et al.
International Journal of Cardiovascular Interventions|December 10, 2002
Clinical and angiographic results with the beStent: the Registry for Optimal beStent Evaluation (ROSE) trialHarry Suryapranata, Jean L Boland, Michael Pieper, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 4, 2025
Elderly patients treated with Onyx versus Orsiro drug-eluting coronary stents in a randomized clinical trial with long-term follow-upDaphne van Vliet, Eline H Ploumen, Tineke H Pinxterhuis, et al.
International Journal of Cardiology. Heart & Vasculature|July 21, 2025
Impact of diabetes on three-year outcome after coronary stenting in patients with polyvascular atherosclerotic disease - a secondary analysis of the randomized TWENTE trialsDaphne van Vliet, Tineke H Pinxterhuis, Eline H Ploumen, et al.
Circulation|November 4, 2005
Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathySaman Nazarian, David A Bluemke, Albert C Lardo, et al.
Cardiovascular Diagnosis and Therapy|September 7, 2023
Outcome of percutaneous coronary intervention using ultrathin-strut biodegradable polymer sirolimus-eluting versus thin-strut durable polymer zotarolimus-eluting stents in patients with comorbid peripheral arterial disease: a post-hoc analysis from two randomized trialsTineke H Pinxterhuis, Eline H Ploumen, Paolo Zocca, et al.
Cardiovascular Intervention and Therapeutics|December 19, 2024
Clinical outcome after bleeding events following coronary stenting in patients with and without comorbid peripheral arterial diseaseTineke H Pinxterhuis, Eline H Ploumen, Marlies M Kok, et al.
Atherosclerosis|May 31, 2022
Outcome after percutaneous coronary intervention with contemporary stents in patients with concomitant peripheral arterial disease: A patient-level pooled analysis of four randomized trialsTineke H Pinxterhuis, Eline H Ploumen, Paolo Zocca, et al.
International Journal of Cardiology|December 10, 2022
Risk of bleeding after percutaneous coronary intervention and its impact on further adverse events in clinical trial participants with comorbid peripheral arterial diseaseTineke H Pinxterhuis, Eline H Ploumen, Paolo Zocca, et al.
Pageof 29